Why At Home Today?

During the 30 years between 1975 and 2005, home hemodialysis nearly disappeared as an option for patients. The NxStage System One’s FDA home clearance in 2005 has led to a new wave of clinical adoption of home hemodialysis. NxStage is leading a movement to improve patient care, and has been told that the community could benefit from timely insight into this progress.

Traditional data registries on dialysis care such as the USRDS and the ESRD Networks cannot structurally provide timely reports on this movement. This is due to data lags (2 years) as well as coding inconsistencies that make capture of information on home hemodialysis and the frequency in which it is delivered challenging. And, home hemodialysis still comprises less than a one percent of the patient population. Particularly during these early years of this rebirth of home dialysis and its enabling technologies, more timely and focused information can be insightful.

From the beginning, NxStage implemented and has maintained a thorough internal database capturing its therapy experience.¹ Thousands of patients and over one million home treatments have added to this insight. The company reviews this information regularly with its Scientific Advisory Board to allow for continuous improvement and education on the therapy. In keeping with NxStage’s commitment to innovate, educate, and advocate, our Scientific Advisory Board recommended that NxStage should make summaries of this information available in a readily accessible, updated format so that folks may be better informed as home daily dialysis clinical adoption spreads through the community.

It is our commitment to the kidney care community to update this information on a regular basis, and to make the data available for public use to those who desire for as long as it is valuable.